Ticker Details
Sagimet Biosciences Inc. Series A
IPO Date:	July 14, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$183.78M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.28 | 4.66%
Avg Daily Range (30 D):	$0.17 | 3.36%
Avg Daily Range (90 D):	$0.18 | 3.10%

Institutional Daily Volume
Avg Daily Volume:	.71M
Avg Daily Volume (30 D):	.32M
Avg Daily Volume (90 D):	.51M

Trade Size
Avg Trade Size (Sh.):	119
Avg Trade Size (Sh.) (30 D):	81
Avg Trade Size (Sh.) (90 D):	89

Institutional Trades
Total Institutional Trades:	67
Avg Institutional Trade:	$1.3M
Avg Institutional Trade (30 D):	$2.11M
Avg Institutional Trade (90 D):	$1.13M
Avg Institutional Trade Volume:	.22M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.48M
Avg Closing Trade (30 D):	$2.11M
Avg Closing Trade (90 D):	$2.11M
Avg Closing Volume:	435.26K

News

Apr 6, 2026 @ 11:00 AM Sagimet Biosciences Announces Poster and Oral Pres... Source: Na

Feb 5, 2026 @ 12:00 PM Sagimet Biosciences Announces Participation in Two... Source: Na

Oct 24, 2025 @ 11:00 AM Denifanstat Achieved All Endpoints in the Treatmen... Source: Sagimet Biosciences

Sep 17, 2025 @ 11:00 AM Positive Phase 3 Results for Denifanstat for the T... Source: Sagimet Biosciences Inc.

Sep 10, 2025 @ 11:00 AM Sagimet Biosciences Announces Upcoming Presentatio... Source: Sagimet Biosciences

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.58	$-.3	$-1.58
Diluted EPS	$-1.58	$-.3	$-1.58
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-51.04M	$-9.57M	$-51.04M
Operating Income / Loss	$-56.89M	$-10.77M	$-56.89M
Cost of Revenue
Net Cash Flow	$-40.82M	$2.53M	$-40.82M
PE Ratio